Cerebral Cortex, Vol. 11, No. 2, 136-147,
February 2001
© 2001 Oxford University Press
Reduced GAP-43 mRNA in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia
Clinical Brain Disorders Branch, IRP/NIMH/NIH, Bldg. 10, Rm. 4N 308, Bethesda, MD 20892-1385, , 1 Stanley Foundation Research Program, 5430 Grosvenor Lane, Suite 200, Bethesda, MD 20814, USA and , 2 Department of Zoology, Bangalore University, Jnanabharathi, Bangalore 560-056, India
Schizophrenia has been associated with anatomical and functional abnormalities of the dorsolateral prefrontal cortex (DLPFC), which may reflect abnormal connections of DLPFC neurons. We measured mRNA levels of growth-associated protein (GAP-43), a peptide linked to the modifiability of neuronal connections, in post-mortem brain tissue from two cohorts of patients with schizophrenia and controls. Using the RNase protection assay (RPA), we found a significant reduction in GAP-43 mRNA in the DLPFC, but not in the hippocampus, of patients with schizophrenia. With in situ hybridization histo- chemistry (ISHH), performed on a separate cohort, we confirmed the reduction of GAP-43 mRNA in the DLPFC of patients with schizophrenia. We detected reduced GAP-43 mRNA per neuron in layers III, V and VI of patients with schizophrenia compared with normal controls and patients with bipolar disorder. Thus, glutamate neurons in DLPFC of schizophrenic patients may synthesize less GAP-43, which could reflect fewer and/or less modifiable connections than those in normal human brain, and which may be consistent with the deficits of prefrontal cortical function that characterize schizophrenia.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. L. Eastwood, L. Lyon, L. George, A. Andrieux, D. Job, and P. J. Harrison Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice J Psychopharmacol, August 1, 2007; 21(6): 635 - 644. [Abstract] [PDF] |
||||
![]() |
S. Akbarian, M. G. Ruehl, E. Bliven, L. A. Luiz, A. C. Peranelli, S. P. Baker, R. C. Roberts, W. E. Bunney Jr, R. C. Conley, E. G. Jones, et al. Chromatin Alterations Associated With Down-regulated Metabolic Gene Expression in the Prefrontal Cortex of Subjects With Schizophrenia Arch Gen Psychiatry, August 1, 2005; 62(8): 829 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Weickert, R. E. Straub, B. W. McClintock, M. Matsumoto, R. Hashimoto, T. M. Hyde, M. M. Herman, D. R. Weinberger, and J. E. Kleinman Human Dysbindin (DTNBP1) Gene Expression in Normal Brain and in Schizophrenic Prefrontal Cortex and Midbrain Arch Gen Psychiatry, June 1, 2004; 61(6): 544 - 555. [Abstract] [Full Text] [PDF] |
||||

